Published on 8 Oct 2024 on GuruFocus.com · via Yahoo Finance
BiomX Inc (PHGE) Q2 2024 Earnings Call Highlights: Strong Financial Turnaround...
Cash Balance: $32.7 million as of June 30, 2024, compared to $30.7 million as of June 30, 2023.Research and Development Expenses: $6.9 million for Q2 2024, up from $3.8 million in Q2 2023.General and Administrative Expenses: $2.8 million for Q2 2024, compared to $2.3 million in Q2 2023.Net Income: $4.5 million for Q2 2024, compared to a net loss of $6.4 million in Q2 2023.Net Cash Used in Operating Activities: $22.6 million for the six months ended June 30, 2024, compared to $9.1 million for the same period in 2023.
Warning! GuruFocus has detected 2 Warning Signs with PHGE.